Prostate Cancer - Results from #180

Efficacy of enzalutamide and apalutamide in the treatment of non-metastasic castration-resistant prostate cancer: Indirect comparison. June 3, 2019

Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials. June 3, 2019

Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. June 3, 2019

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer June 2, 2019

Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study. June 2, 2019

Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis. May 31, 2019

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement. May 31, 2019

Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy. May 31, 2019

Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study. May 31, 2019

Vasectomy and prostate cancer risk: a 38-year nationwide cohort study. May 31, 2019

NCCN Guidelines Updates: Management of Prostate Cancer. May 31, 2019

Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States. May 31, 2019

STOMPing Out Hormone-Sensitive Metastases With Local Therapies in Prostate Cancer. May 31, 2019

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer. May 31, 2019

High ductal proportion predicts biochemical recurrence in prostatic ductal adenocarcinoma. May 30, 2019

User-testing an interactive option grid decision aid for prostate cancer screening: lessons to improve usability. May 30, 2019

Who Dies From Prostate Cancer? An Analysis of the Surveillance, Epidemiology and End Results Database. May 30, 2019

Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy. May 30, 2019

The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels. May 30, 2019

Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer. May 30, 2019

Page 10 of 989

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.